SearchDictionaryMobileLogin

Stephan Oertel Selected Research

Lymphoproliferative Disorders (Lymphoproliferative Disorder)

12/2007Salvage therapy for relapsed posttransplant lymphoproliferative disorders (PTLD) with a second progression of PTLD after Upfront chemotherapy: the role of single-agent rituximab.
08/2007Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.
04/2007Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
02/2007CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation.
07/2006Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.

Articles by Research Topic

Disease

5Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2007 - 07/2006
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2008
1Wilms Tumor (Wilm's Tumor)
12/2004

Drug/Important Bio-Agent (IBA)

4rituximab (Mabthera)FDA Link
01/2008 - 04/2007

Therapy/Procedure

3Drug Therapy (Chemotherapy)
12/2007 - 12/2004
3Organ Transplantation
08/2007 - 07/2006
1Salvage Therapy
12/2007
1Transplantation (Transplant Recipients)
08/2007
1Aftercare (After-Treatment)
04/2007
1Transplants (Transplant)
02/2007